Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ESRRA | P11474 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623103 | 0.89 | NUDT1 (0.49) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL13609954 | 0.89 | NUDT1 (0.49) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL29368513 | 0.87 | NUDT1 (0.50) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL68186 | 0.87 | NUDT1 (0.50) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL29458615 | 0.85 | ESR1 (0.49) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL2340495 | 0.85 | ESR1 (0.49) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL17354422 | 0.85 | NUDT1 (0.46) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL2309797 | 0.83 | NUDT1 (0.44) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL20717757 | 0.83 | ESR1 (0.50) | HSP90AA1NUDT1BACE1ACMSDESR1 | |
| SCHEMBL11054583 | 0.83 | HSP90AA1 (0.53) | HSP90AA1NUDT1BACE1ACMSDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9567281-B2 | 4-acylaralkylphenols and derivatives thereof | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2017-02-14 | — | — | US | disclosed |
| US-9090547-B2 | Method for producing trisphenols and monoester-substituted products thereof, and 4-acylaralkylphenol derivatives | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2015-07-28 | — | — | US | disclosed |
| US-20140221680-A1 | 4-Acylaralkylphenols and Derivatives Thereof | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20120108853-A1 | METHOD FOR PRODUCING TRISPHENOLS AND MONOESTER-SUBSTITUTED PRODUCTS THEREOF, AND 4-ACYLARALKYLPHENOL DERIVATIVES | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221680-A1 | 4-Acylaralkylphenols and Derivatives Thereof | UGT1A7, CYP19A1, UGT2B7 | HSP90AA1 3651/4885NUDT1 1506/4885BACE1 4775/4885 |
| US-20120108853-A1 | METHOD FOR PRODUCING TRISPHENOLS AND MONOESTER-SUBSTITUTED PRODUCTS THEREOF, AND 4-ACYLARALKYLPHENOL DERIVATIVES | CYP19A1, MTTP, CYP4X1 | HSP90AA1 2531/4885NUDT1 1568/4885BACE1 4476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.